Hypoxanthine

From NuGOwiki

(Redirected from HMDB00157)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Hypoxanthine
2D structure for Hypoxanthine
Chemical Name 3,7-dihydropurin-6-one
Chemical Formula C5H4N4O
CAS Number 68-94-0
Chemical Information HMDB00157
Biochemical Taxonomy

  • Purines and Purine Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Nicotinate and Nicotinamide Metabolism
  • Purine Metabolism

Biofluid Location

  • Blood
  • Cellular Cytoplasm
  • Cerebrospinal Fluid (CSF)
  • Urine

Tissue Location

  • Epidermis
  • Erythrocyte
  • Fibroblasts
  • Intestine
  • Muscle
  • Placenta
  • Platelet
  • Skeletal Muscle
  • Spleen
  • Testes
  • Adipose Tissue

Normal Biofluid Concentrations

  • Blood: 0.38 (0.20-0.56) uM
  • Blood: 1.0 +/- 0.9 uM
  • Blood: 4.87 +/- 0.36 umol/L
  • Blood: 5.6 (3.1-7.1) uM
  • Cellular Cytoplasm: 2 uM
  • Cerebrospinal Fluid (CSF): 5.94 (5.20-6.68) uM
  • Urine: 4.67 (2.8-6.38) umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Degenerative disc disease
  • Lung Cancer
  • Non-compensated hydrocephalics (pre-shunt implanted)
  • Patients with Canavan disease
  • Patients with Lesch-Nyhan syndrome
  • Self-compensated hydrocephalics

Other (Monogenic Disorders)

Abnormal Biofluid Concentrations

  • Blood (Patients with Canavan disease): 5.56 +/- 1.74 umol/L
  • Blood (Patients with Lesch-Nyhan syndrome): 5.7 +/- 0.4 umol/L
  • Cerebrospinal Fluid (CSF) (Degenerative disc disease): 2.50 (2.00-3.00) uM
  • Cerebrospinal Fluid (CSF) (Non-compensated hydrocephalics (pre-shunt implanted)): 9.91 (8.01-11.8) uM
  • Cerebrospinal Fluid (CSF) (Self-compensated hydrocephalics): 5.71 (3.99-7.43) uM
  • Urine (Lung Cancer): 6.8 +/- 4.8 umol/mmol creatinine

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
A naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is also a spontaneous deamination product of adenine. Lesch-Nyhan disease is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase. (OMIN 308000).

Biological Function

guidelines

Catabolism

guidelines
Hypoxanthine is a purine base generated from degradation of adenine and guanine nucleotides. Xanthine can be generated from hypoxanthine by oxidation.

Diseases / Conditions Related to Nutrition

guidelines

  • Degenerative disc disease
  • Lung Cancer
  • Non-compensated hydrocephalics (pre-shunt implanted)
  • Patients with Canavan disease
  • Patients with Lesch-Nyhan syndrome
  • Self-compensated hydrocephalics

Other (Monogenic) Disorders

guidelines

Nutritional Information

guidelines

Drivers for biological variation

guidelines
Shaham O et al. observed decreased concentrations of hypoxanthine and xanthine upon a glucose challenge test Pubmed. Their explanation was that the decrease in hypoxanthine and xanthine may be explained by a combination of attenuated release and accelerated uptake. Hypoxanthine taken up by tissues can support nucleotide biosynthesis through the purine salvage pathway and may also be indicative of a switch from catabolism to anabolism of nucleic acids, analogues to the simultaneous transitions in fat and protein metabolism.

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines